Ignite Creation Date:
2024-05-06 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05876832
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-26
First Post:
2023-05-17
Brief Title:
A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation ALIVE
Sponsor:
Organization:
Shijiazhuang Yiling Pharmaceutical Co Ltd